Association Between Early Immune-related Adverse Events and Clinical Outcomes in Patients With Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
暂无分享，去创建一个
T. Morimoto | J. Uchida | Hidekazu Suzuki | K. Hirano | T. Ishida | T. Hirashima | T. Yokoyama | M. Tamiya | A. Tamiya | T. Kumagai | D. Fujimoto | S. Hara | Nobuhiko Sawa | K. Tomii | Y. Taniguchi | M. Kanazu | M. Morita | K. Hosoya | H. Matsumoto | Ryota Kominami | T. Makio | N. Sawa